Picture of Orthofix Medical logo

OFIX — Orthofix Medical News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Orthofix Medical Inc expected to post earnings of 12cents a share - Earnings Preview

* Orthofix Medical Inc  OFIX.OQ   OFIX.O  is expected
to show a
rise in quarterly revenue when it reports  results on November
3. 
    * The Lewisville Texas-based  company is expected to report 
a
0.5% increase in revenue to $113 million from $112.43 million a
year ago, according to the mean estimate from 4 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Orthofix Medical
Inc is
for earnings of 12 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 3 "strong buy" or
"buy," 1 "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Orthofix
Medical
Inc is $30​, above​ its last closing price of $16.06. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2022  0.10        0.10       0.08      Missed  -20
 Mar. 31 2022  0.10        0.09       -0.10     Missed  -215.4
 Dec. 31 2021  0.13        0.13       0.27      Beat    107.7​
 Sep. 30 2021  0.11        0.11       0.10      Missed  -10.4
 ​​Jun.        0.13        0.11       0.32      Beat    190.9
 30 2021                                                
 Mar. 31 2021  0.01        0.02       0.17      Beat    709.5​
 Dec. 31 2020  0.17        0.19       0.44      Beat    126.8
 Sep. 30 2020  -0.29       -0.36      0.31      Beat    185.2
 This summary was machine generated November 1 at 18:34 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Orthofix Medical

See all news